Long-Term Hepatitis B Vaccine Immunity in Ethiopian Children That Received a Pentavalent Vaccine Series: A Retrospective Cohort Study
Background: Chronic hepatitis B affects close to 300 million people globally with 1.5 million new infections per year. It causes the highest numbers of cirrhosis and liver cancer diagnoses each year. In children, perinatal transmission and contact with infected blood or body fluids remain the main m...
Main Authors: | Tinsae Alemayehu, Million Dechassa Daba, Danilo Buonsenso |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-01-01
|
Series: | Children |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9067/11/1/136 |
Similar Items
-
Revaccination against hepatitis B in late teenagers who received vaccination during infancy: Yes or no?
by: Hong Zhao, et al.
Published: (2018-02-01) -
Medicinal Plants in Treating Hepatitis B Among Communities of Central Region of Ethiopia
by: Beykaso G, et al.
Published: (2023-12-01) -
Children with trisomy 21 are a group at risk for severe COVID-19: Case reports from a COVID-19 treatment unit in Addis Ababa, Ethiopia
by: Tinsae Alemayehu, et al.
Published: (2022-10-01) -
A booster hepatitis B vaccine for children with maternal HBsAg positivity before 2 years of age could effectively prevent vaccine breakthrough infections
by: Yarong Song, et al.
Published: (2022-11-01) -
Medicinal Plants Used for the Management of Hepatitis Over the Past 15 Years in Ethiopia: A Systematic Review
by: Aschale Y, et al.
Published: (2023-03-01)